Thrombotic risk assessment: A hybrid approach

The Vein Book

Volumn , Issue , 2007, Pages 359-367

  Caprini, Joseph A ^a  

^a Evanston Northwestern Healthcare ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882815232     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369515-4/50044-2     Document Type: Chapter

References (58)

1. Shojania KG, Duncan BW, McDonald KM, et al. Making health care safer: A critical analysis of patient safety practices. Evid Rep Technol Assess (Summ) 2001, 43(i-x):1-668.
2. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thrombo-embolism: The Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004, 126:338S-400S.
3. Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical department: Analysis of the period from1951to 1968. Br J Surg. 1991, 78:849-852.
4. Hyers TM. Venous thromboembolism. Am J Respir Crit Care Med. 1999, 159:1-14.
5. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996, 125:1-7.
6. Bergqvist D, Jendteg S, Johansen L, et al. Cost of long-term complica-tions of deep vein thrombosis of the lower extremities: An analysis of a defined patient population in Sweden. Ann Intern Med. 1997, 126:454-457.
7. Nicolaides AN, Bergqvist D, Hull RD, et al. Prevention of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 1997, 16:3-38.
8. Nicolaides AN, Breddin HK, Fareed J, et al. Prevention of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2001, 20(1):1-37.
9. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992, 305:567-574.
10. Second Thromboembolic Risk Factors (THRIFT II) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology. 1998, 13:87-97.
11. Stratton MA, Anderson FA, Bussey HI, et al. Prevention of venous thromboembolism: Adherence to the American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med. 2000, 14(160):334-340.
12. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: An evaluation of the use of thromboprophy-laxis guidelines. Chest. 2001, 120:1964-1971.
13. Anderson FA, Tapson VF, Decousus H, et al. IMPROVE a multina-tional observational cohort study of practices in prevention of venous thromboembolism in acutely ill medical patients: A comparison with clinical study populations. Blood. 2003, 102:3l9a.
14. Caprini JA, Glase C, Martchev D, et al. Thrombosis risk factor assess-ment in surgical patients: Compliance with chest consensus guidelines. J Thromb Haemost. 2003, 1(Suppl 1):CD125.
15. Friedman R, Gallus A, Cushner F, et al. Compliance with ACCP guide-lines for prevention of venous thromboembolism: Multinational find-ings from the global orthopaedic registry (GLORY). Blood. 2003, 102:165a.
16. Panju A, Kahn SR, Geerts W, et al. Utilization of venous thrombopro-phylaxis in acutely ill medical patients in Canada: Results from the Canadian Registry (CURVE). Blood. 2003, 102:498a.
17. Caprini JA, Arcelus JI. State-of-the-art venous thromboembolism pro-phylaxis. Scope on Phlebology and Lymphology. 2001, 1:228-240.
18. Anderson FA Jr, Audet A-M, St John R. Practices in the prevention of venous thromboembolism. J Thromb Thrombolysis. 1998, 5:S7-S11.
19. Bratzler DW, Raskob GE, Murray CK, et al. Underuse of venous throm-boembolism prophylaxis for general surgery patients: Physician prac-tices in the community hospital setting. Arch Intern Med. 1998, 158:2009-2912.
20. Ahmad HA, Geissler A MacLellan DG. Deep venous thrombosis pro-phylaxis: Are guidelines being followed? ANZ J Surg. 2002, 72:331-334.
21. Huber O, Bournameaux H, Borst F, Rohner A. Postoperative pulmo-nary embolism after hospital discharge: An underestimated risk. Arch Surg. 1992, 127:310-313.
22. Bergqvist D. Long-term prophylaxis following orthopedic surgery. Haemostasis. 1993, 23(Suppl 1):27-31.
23. Trowbridge A, Boese CK, Woodruff B, et al. Incidence of posthospitali-zation proximal deep venous thrombosis after total hip arthroplasty. A pilot study. Clin Orthop. 1994, 299:203-208.
24. White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998, 158:1525-1531.
25. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thrombo-embolism verified by necropsy over 30 years. BMJ. 1991, 302:709-711.
26. Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospi-talised medical patients. J Clin Pathol. 1997, 50:609-610.
27. Gensini GF, Prisco D, Falciani M, et al. Identification of candidates for prevention of venous thromboembolism. Semin Thromb Hemost. 1997, 23:55-67.
28. Kakkar AK, Williamson RC. Prevention of venous thromboembolism in cancer using low-molecular-weight heparins. Haemostasis. 1997, 27:32-37.
29. McNally MA, Cooke EA, Harding ML, Mollan RA. Attitudes to utilization of low molecular weight heparins in joint replacement surgery. J R Coll Surg Edinb. 1997, 42:407-409.
30. Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Grou. Lancet. 1993, 341:259-265.
31. Koch A, Bouges S, Ziegler S, et al. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses. Br J Surg. 1997, 84:750-759.
32. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of a meta-analysis. Ann Surg. 1988, 208:227-240.
33. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmo-nary embolism venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general orthopedic and urologic surgery. N Engl J Med. 1988, 318:1162-1173.
34. Nurmohamed MT, Rosendaal FR, Buller HR, et al. Low molecular weight heparin versus standard heparin in general and orthopedic surgery: A metaanalysis. Lancet. 1992, 340:152-156.
35. Jorgensen LN, Wille-Jorgensen P, Hauch O. Prophylaxis of postopera-tive thromboembolism with low molecular weight heparins. Br J Surg. 1993, 80:689-704.
36. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocy-topenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med. 1995, 332:1330-1335.
37. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative ortho-pedic patients. Arch Intern Med. 2003, 163:2518-2524.
38. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thrombo-embolism: The Sixth ACCP conference on antithrombotic and throm-bolytic therapy. Chest. 2001, 119:132S-175S.
39. Caprini JA, Botteman MF, Stephens JM, et al. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health. 2003, 6:59-74.
40. Agu O, Hamilton G, Baker D. Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg. 1999, 86:992-1004.
41. Wheeler HB. Diagnosis of deep vein thrombosis.eview of clinical evaluation and impedance plethysmography. Am J Surg. 1985, 150:7-13.
42. Flordal PA, Bergqvist D, Burmark US, et al. Risk factors for major thromboembolism bleeding tendency after elective general surgery operations. The Fragmin Multicentre Study Group. Eur J Surg. 1996, 162:783-789.
43. Caprini JA, Arcelus JI, Hasty JH, et al. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991, 17:304-312.
44. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: Analysis of the MEDENOX study. Arch Intern Med. 2004, 164:963-968.
45. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001, 38(suppl 5):12-19. 2.
46. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002, 346:975-980.
47. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med. 2000, 160:809-815.
48. Bergqvist D, Burmark U, Flordal P, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg. 1995, 82:496-501.
49. Borow M, Goldson HJ. Prevention of postoperative deep vein throm-bosis and pulmonary emboli with combined modalities. Am Surg. 1983, 49(11):599-605.
50. Borow M, Goldson HJ. Postoperative venous thrombosis. Evalua-tion of five methods of treatment. Am J Surg. 1981, 141(2):245-251.
51. Kucher N, Koo S, Quiroz, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005, 352:969-977.
52. Lee AYY, Rickles FR, Julian JA, et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol. 2005, 23(10):1-7.
53. Lee AYY, Levine MN, Blaer RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboem-bolism in patients with cancer. N Engl J Med. 2003, 349:146-153.
54. Mismetti P, Laporte S, Darmon JY, Buchmüller Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001, 88:913-930.
55. Mousa SA, Mohamed S. Anti-angiogenic mechanisms efficacy of the low molecular weight heparin tinzaparin: Anti-cancer efficacy. Oncol Rep. 2004, 12(4):683-688.
56. Rasmussen MS, Jorgensen L, Wille-Jorgensen et al Prolonged prophy-laxis with dalteparin after major abdominal surgery 2001, OC1733, Throm Haemost.
57. Rasmussen MS. Preventing thromboembolic complications in cancer patients after surgery: A role for prolonged thromboprophylaxis. Cancer Treat Rev. 2002, 28:141-144.
58. Turple AG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz J. Fondaparineux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of VTE after major abdominal surgery: results of APOL. J Thromb Haemost. 2005, 3(Suppl 1). Abstract P1046. (Abs).